证券之星消息，2025年7月25日赛分科技（688758）发布公告称易方达基金、南方基金于2025年7月24日调 研我司。 具体内容如下： 公司与投资者针对行业情况、产品市场动态等方面进行了交流，沟通主要内容与公司公告内容一致，部分 延伸探讨内容纪要如下： 问：公司的业务发展与医药行业投融资情况是否具有显著相关性？ 答：复公司工业纯化业务增长主要以"国产替代+项目自然推进"双引擎驱动，叠加高技术壁垒、高粘性客 户和持续技术支持服务等优势，公司业务得以在医药行业投融资波动中展现出较强韧性，近年来保持持续 稳健增长。 问：行业的进入壁垒体现在哪里，公司的竞争优势如何体现？ 答：复行业壁垒集中于长期技术积累、规模化生产与质量控制以及客户粘性。公司竞争优势包括，1、技 术积累色谱介质需整合材料科学、蛋白工程学等多学科技术，涉及微球合成、表面修饰、功能化修饰等核 心工艺，公司深耕色谱领域 20余年，掌握大量具有全球通用性的专有技术（know-how）和技术机密 （trade secret）；2、规模化生产与质量控制公司拥有工业纯化填料规模化生产的条件并建成高水平质量 管理体系，通过 100+家药企客户的供应商审计，并在 ...

据证券时报记者了解，江苏上市公司"硬科技"属性突出，八成以上新增上市公司将募集资金用于研发创新 或者技术升级；平均每家科创板上市公司年度研发投入超2亿元，上市公司已成为推动区域科技创新的重 要力量。 江苏证监局相关负责人表示，该局认真落实证监会党委和江苏省委、省政府工作部署，全面强化央地协 同，抓住"有效发挥资本市场功能"与"提升行政监管执法效能"两个重要支点，在激发市场活力与坚守风险 底线间实现动态平衡，助力江苏打造一流法治化营商环境，为全国资本市场稳定运行作贡献。 "军团"提速 1993年，无锡太极实业成功叩响资本市场的大门，江苏第一家上市公司由此诞生；30多年后，江苏境内 上市公司数量迈入"700+"时代。 以下文章来源于e公司 ，作者臧晓松 陈澄 e公司 . e公司，证券时报旗下专注上市公司新媒体产品，立志打造A股上市公司资讯第一平台。提供7x24小时 上市公司标准化快讯，针对可能影响上市公司股价的主题概念、行业事件及时采访二次解读，从投资者 需求出发，直播上市公司有价值的活动、会议。 3月25日上午，胜科纳米在上交所科创板鸣锣上市，江苏境内上市公司数量正式迈入"700+"时代，高质量 发展基础更加扎 ...

Core Viewpoint - Jiangsu's capital market has reached a new milestone with over 700 listed companies, reflecting a robust foundation for high-quality development and significant contributions to regional technological innovation [1][3][20]. Group 1: Growth of Listed Companies - Jiangsu has officially entered the "700+" era with a total of 700 listed companies, including 216 on the Shanghai Stock Exchange, 113 on the Sci-Tech Innovation Board, and 48 on the Beijing Stock Exchange [1][3]. - Since the implementation of the registration system, Jiangsu has added 320 new listed companies, accounting for over 45% of the total, indicating accelerated growth in the number and scale of listed companies [3][4]. - The average annual R&D investment for each Sci-Tech Innovation Board company exceeds 200 million yuan, highlighting the emphasis on innovation and technology upgrades [1][10]. Group 2: Regional Distribution and Industry Focus - Suzhou, Nanjing, and Wuxi are the top three cities in Jiangsu with over 100 listed companies each, with Suzhou leading at 220 companies, particularly strong in electronics, biomedicine, and high-end equipment manufacturing [3][4]. - Jiangsu's manufacturing sector is significant, with 549 manufacturing companies listed, representing nearly 80% of the total listed companies in the region [4][10]. Group 3: Innovation and Technology - Jiangsu's listed companies are heavily focused on "hard technology," with over 80% of new listings planning to use raised funds for R&D or technology upgrades [1][10]. - The total R&D investment of Jiangsu's Sci-Tech Innovation Board companies in 2023 exceeded 20 billion yuan, with notable contributions from companies like Trina Solar and Huazhong Microelectronics [10][11]. Group 4: Future Industries and New Opportunities - Jiangsu is actively cultivating future industries such as biomanufacturing, commercial aerospace, quantum technology, and humanoid robotics, with core enterprises generating over 500 billion yuan in revenue [14][15]. - Companies like XCMG Machinery and Lead Intelligent are leading in their respective fields, with significant advancements in high-end machinery and new energy equipment [7][8]. Group 5: Capital Market Development and Policies - Jiangsu's regulatory body is enhancing collaboration with local governments to promote a stable and healthy capital market, focusing on innovation and supporting private enterprises [12][20]. - The implementation of new policies has led to an increase in cash dividends among listed companies, with 648 companies distributing a total of 132 billion yuan in dividends in 2024 [18][19].